Next Article in Journal
Slower Waning of Anti-SARS-CoV-2 IgG Levels Six Months after the Booster Dose Compared to Primary Vaccination
Next Article in Special Issue
Molecular Lipopolysaccharide Di-Vaccine Protects from Shiga-Toxin Producing Epidemic Strains of Escherichia coli O157:H7 and O104:H4
Previous Article in Journal
Institutional Factors Associated with Infection Prevention and Control Practices Globally during the Infectious Pandemics in Resource-Limited Settings
Previous Article in Special Issue
Immunoinformatics Studies and Design of a Potential Multi-Epitope Peptide Vaccine to Combat the Fatal Visceral Leishmaniasis
 
 
Article

Article Versions Notes

Vaccines 2022, 10(11), 1812; https://doi.org/10.3390/vaccines10111812
Action Date Notes Link
article xml file uploaded 28 October 2022 06:23 CEST Original file -
article xml uploaded. 28 October 2022 06:23 CEST Update https://www.mdpi.com/2076-393X/10/11/1812/xml
article pdf uploaded. 28 October 2022 06:23 CEST Version of Record https://www.mdpi.com/2076-393X/10/11/1812/pdf
article html file updated 28 October 2022 06:24 CEST Original file -
article html file updated 28 February 2023 20:16 CET Update -
article html file updated 2 March 2023 01:04 CET Update https://www.mdpi.com/2076-393X/10/11/1812/html
Back to TopTop